Reports

Sepsis poses one of the greatest challenges in healthcare today, with approximately 1.7 million cases and 270,000 deaths annually in the United States alone. The condition is the most expensive to treat in US hospitals, highlighting the urgent need for effective diagnosis and treatment solutions. Kalorama Information’s report, Sepsis Diagnostics Products and Market Trends, provides…

The chemical industry, sandwiched downstream of oil & gas and upstream of pharmaceuticals, foods, and other manufacturing industries, is the backbone of most industrial processes, providing the key raw materials needed for the vast majority of end-use consumer products. Encompassing commodity chemicals, specialty chemicals, and fine chemicals, laboratories within this industry comprise about 5% of…

This report provides an in-depth and up-to-date look into scientists’ use of the genome editing tool, CRISPR/Cas9. Our survey reveals that while the market is growing steadily, there are challenges confronting suppliers. For instance, Bioinformatics found that over a quarter of scientist respondents said they were highly or somewhat likely to switch away from their primary brand…

The Worldwide Market for Laboratory-Developed Tests (LDTs), 2nd Edition provides a comprehensive analysis of the global sequencing market. This report covers market trends, challenges, strategies, and detailed profiles of key companies and products. It includes precise market share estimates and revenue growth forecasts, offering insights into the competitive landscape, including major deals and product developments.…

Urgent care centers (UCCs) are a vital and growing segment of the U.S. healthcare system, with around 10,000 locations nationwide. They offer walk-in care, a broad range of services, extended hours, and minimal wait times. Kalorama Information’s report, The U.S. Market for Urgent Care Centers (Including COVID-19, POC Tests, Vaccines and Other Sales), 2^nd Edition,…

We’ve Spoken To Your Customers

Understanding the overall customer experience, from pre-purchase experience, to product experience, to post-purchase experience, is more important now than ever before. Customer experience offers an opportunity for suppliers to differentiate themselves from other suppliers in a crowded life science marketplace on something more than product performance and price. An excellent…

For most manufacturing facilities in the food industry, laboratories must first test the raw materials that are purchased from an external supplier or farm. This must occur before they are allowed to be processed by the manufacturer. As the raw materials are processed, they are usually tested or monitored in some way. Samples tested during…

Environmental testing is a key area of the global analytical instrumentation market that looks at qualitatively and/or quantitatively analyzing contaminants in the environment. These contaminants can take many forms, from toxic chemicals in drinking water as the result of industrial processes to small particulate matter in the air we breathe. In order to protect from…

Customer experience in the clinical diagnostics industry is increasingly a target for improving overall customer satisfaction and a potential opportunity for differentiation beyond product performance, service plans, and price. This Kalorama Information report is an essential tool to learn how the in vitro diagnostics industry is seen from the point of view of their customers.

…

The SDi Global Assessment Report 2020: The Laboratory Analytical & Life Science Instrumentation Industry is the gold standard for market research reports in the analytical and life science instrument market.

Updated June 2020 to reflect the COVID-19 and related lab closure situation.

This report provides detailed data on every major life science and analytical instrument technology…

Companion diagnostics are revolutionizing pharmaceutical development and treatment, particularly in oncology. By identifying patients with specific biomarkers or disease-specific therapeutic targets, companion diagnostics significantly improve clinical success rates and patient outcomes. They also reduce costs by pinpointing the patient population most likely to benefit from a therapy and excluding those for whom the therapy would…